Northland Capmk Lowers Transcat (NASDAQ:TRNS) to Hold

Northland Capmk cut shares of Transcat (NASDAQ:TRNS) from a strong-buy rating to a hold rating in a report released on Wednesday, Zacks.com reports. Northland Capmk also issued estimates for Transcat’s FY2025 earnings at $1.99 EPS, FY2026 earnings at $2.15 EPS, FY2027 earnings at $2.27 EPS, FY2028 earnings at $2.59 EPS and FY2029 earnings at $2.85 EPS.

A number of other equities analysts have also recently issued reports on the company. HC Wainwright increased their target price on Transcat from $124.00 to $156.00 and gave the stock a buy rating in a report on Wednesday. TheStreet upgraded Transcat from a c+ rating to a b rating in a report on Wednesday, January 31st. Northland Securities cut Transcat from an outperform rating to a market perform rating in a report on Wednesday. Finally, Oppenheimer raised their price objective on Transcat from $125.00 to $160.00 and gave the company an outperform rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of Hold and an average price target of $142.67.

Transcat Price Performance

TRNS opened at $134.51 on Wednesday. The company has a fifty day simple moving average of $114.10 and a 200 day simple moving average of $106.47. The stock has a market cap of $1.19 billion, a P/E ratio of 84.60 and a beta of 0.61. The company has a quick ratio of 2.81, a current ratio of 3.37 and a debt-to-equity ratio of 0.01. Transcat has a 12 month low of $81.26 and a 12 month high of $147.00.

Insider Activity at Transcat

In other news, CEO Lee D. Rudow sold 2,373 shares of Transcat stock in a transaction that occurred on Saturday, March 30th. The shares were sold at an average price of $111.43, for a total value of $264,423.39. Following the completion of the sale, the chief executive officer now directly owns 103,688 shares in the company, valued at $11,553,953.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CEO Lee D. Rudow sold 2,373 shares of Transcat stock in a transaction that occurred on Saturday, March 30th. The shares were sold at an average price of $111.43, for a total value of $264,423.39. Following the completion of the sale, the chief executive officer now directly owns 103,688 shares in the company, valued at $11,553,953.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Lee D. Rudow sold 3,343 shares of Transcat stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $124.12, for a total transaction of $414,933.16. Following the completion of the sale, the chief executive officer now owns 103,692 shares of the company’s stock, valued at $12,870,251.04. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,716 shares of company stock worth $2,300,557. Insiders own 4.20% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. State Board of Administration of Florida Retirement System bought a new position in Transcat in the third quarter valued at approximately $207,000. Arizona State Retirement System bought a new position in Transcat in the third quarter valued at approximately $213,000. Virtu Financial LLC bought a new position in Transcat in the first quarter valued at approximately $224,000. Quantbot Technologies LP increased its stake in Transcat by 118.2% in the third quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company’s stock valued at $232,000 after acquiring an additional 1,284 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of Transcat by 13.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,347 shares of the scientific and technical instruments company’s stock worth $262,000 after buying an additional 284 shares during the last quarter. 98.34% of the stock is owned by institutional investors.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.